CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-07 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units | −34,090 | 34,091 | ||
| 2022-06-07 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units | −13,638 | 27,270 | ||
| 2022-06-07 | Barton Shane VP & Corporate Controller | Option exercise | +6,061 | 8,720 | ||
| 2022-06-07 | Barton Shane VP & Corporate Controller | Option exercise · Restricted Stock Units | −6,061 | 12,120 | ||
| 2022-05-26 | Brown Melinda Director | Grant or award · Stock Option (Right to Buy) | +376,683 | 376,683 | ||
| 2022-05-10 | Pire Shari Lisa Director | Grant or award · Stock Option (Right to Buy) | +156,951 | 156,951 | ||
| 2022-05-10 | Wadsworth Samuel C. Director | Grant or award · Stock Option (Right to Buy) | +156,951 | 156,951 | ||
| 2022-05-10 | Germano Geno J Director | Grant or award · Stock Option (Right to Buy) | +156,951 | 156,951 | ||
| 2022-05-10 | Frankel Stanley Director | Grant or award · Stock Option (Right to Buy) | +156,951 | 156,951 | ||
| 2022-05-10 | Schinazi Raymond F Director | Grant or award · Stock Option (Right to Buy) | +156,951 | 156,951 | ||
| 2022-05-10 | Buehler Kevin Director | Grant or award · Stock Option (Right to Buy) | +156,951 | 156,951 | ||
| 2022-04-27 | List Alan Chief Medical Officer | Sale | −7,775 | $2.10 | $16K | 18,260 |
| 2022-04-26 | List Alan Chief Medical Officer | Option exercise | +26,035 | 26,035 | ||
| 2022-04-26 | List Alan Chief Medical Officer | Option exercise · Restricted Stock Units | −26,035 | 52,055 | ||
| 2022-04-11 | Buehler Kevin Director | Grant or award · Stock Option (Right to Buy) | +8,763 | 8,763 | ||
| 2022-04-11 | Buehler Kevin Director | Grant or award · Restricted Stock Units | +5,701 | 5,701 | ||
| 2022-03-21 | Amoroso Michael President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +482,771 | 482,771 | ||
| 2022-03-21 | Amoroso Michael President and CEO | Grant or award · Restricted Stock Units | +307,544 | 307,544 | ||
| 2022-03-17 | Kelly John Alexander Chief Financial Officer | Purchase | +16,677 | $3.08 | $51K | 36,189 |
| 2022-03-03 | List Alan Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +140,299 | 140,299 |
Page 16 of 23 · 456 trades